Drug Trial Radar · NCT00463606
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
Last checked: Nov 20, 2026Latest source record: Oct 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
760
Actual
Start
Apr 2007
Primary completion
Feb 2008
Study completion Feb 2008
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 20, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of ABT-335 and rosuvastatin calcium combination therapy to monotherapy in subjects with dyslipidemia.
Conditions
- Hypercholesterolemia
- Dyslipidemia
Interventions
ABT-335 and rosuvastatin calciumDrug
ABT-335 135 mg in combination with rosuvastatin calcium 5 mg administered orally, once daily for 12 weeks
ABT-335Drug
ABT-335 135 mg monotherapy administered orally, once daily for 12 weeks
rosuvastatin calciumDrug
Rosuvastatin calcium 5 mg monotherapy administered orally, once daily for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline to the Final Visit in High-density Lipoprotein Cholesterol (HDL-C) (Full Analysis Set)Time frame: Baseline to 12 Weeks
- Mean Percent Change From Baseline to the Final Visit in Triglycerides (Full Analysis Set)Time frame: Baseline to 12 Weeks
- Mean Percent Change From Baseline to the Final Visit in Low-density Lipoprotein Cholesterol (LDL-C) (Full Analysis Set)Time frame: Baseline to 12 Weeks
Locations
168 sites in 1 country. Site status is shown where the registry gives one.
Site Reference ID/Investigator# 5469
Birmingham, Alabama
Site Reference ID/Investigator# 4428
Birmingham, Alabama
Site Reference ID/Investigator# 4985
Birmingham, Alabama
Site Reference ID/Investigator# 4493
Huntsville, Alabama
Site Reference ID/Investigator# 4510
Huntsville, Alabama
Site Reference ID/Investigator# 4431
Ozark, Alabama
Site Reference ID/Investigator# 4519
Tuscaloosa, Alabama
Site Reference ID/Investigator# 4395
Chandler, Arizona
Site Reference ID/Investigator# 4483
Gilbert, Arizona
Site Reference ID/Investigator# 4411
Scottsdale, Arizona
Site Reference ID/Investigator# 4417
Little Rock, Arkansas
Site Reference ID/Investigator# 4702
Anaheim, California
Site Reference ID/Investigator# 5593
Chula Vista, California
Site Reference ID/Investigator# 4503
Concord, California
Site Reference ID/Investigator# 4530
Encinitas, California
Site Reference ID/Investigator# 4458
Fair Oaks, California
Site Reference ID/Investigator# 4542
Fresno, California
Site Reference ID/Investigator# 4574
Fresno, California
Site Reference ID/Investigator# 4441
Lincoln, California
Site Reference ID/Investigator# 4432
Long Beach, California
Site Reference ID/Investigator# 5579
Los Angeles, California
Site Reference ID/Investigator# 4980
Norwalk, California
Site Reference ID/Investigator# 4392
Sacramento, California
Site Reference ID/Investigator# 4896
Sacramento, California
Site Reference ID/Investigator# 5582
San Diego, California
Site Reference ID/Investigator# 6236
West Hills, California
Site Reference ID/Investigator# 4442
Aurora, Colorado
Site Reference ID/Investigator# 4419
Colorado Springs, Colorado
Site Reference ID/Investigator# 4391
Waterbury, Connecticut
Site Reference ID/Investigator# 4401
Coral Gables, Florida
Site Reference ID/Investigator# 4453
Fort Lauderdale, Florida
Site Reference ID/Investigator# 4490
Holly Hill, Florida
Site Reference ID/Investigator# 4420
Hollywood, Florida
Site Reference ID/Investigator# 5011
Jacksonville, Florida
Site Reference ID/Investigator# 4444
Jacksonville, Florida
Site Reference ID/Investigator# 4399
Jupiter, Florida
Site Reference ID/Investigator# 4433
Kissimmee, Florida
Site Reference ID/Investigator# 4469
Largo, Florida
Site Reference ID/Investigator# 4525
Melbourne, Florida
Site Reference ID/Investigator# 4477
Miami, Florida
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.